4/A
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0000899243-17-026845
Chairman sold 40,000 shares at an average $40.37 ($1,614,800)
- Chairman acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
El-Hibri Fuad · Chairman
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-13 | Exercise or conversion : show line 1 in the form | +20,000 | $22.03 | $440,600 | 1,550,216 | D |
| 2017-11-13 | Sale : show line 2 in the form | −20,000 | $40.69 | $813,800 | 1,530,216 | D |
| 2017-11-14 | Exercise or conversion : show line 3 in the form | +20,000 | $22.03 | $440,600 | 1,550,216 | D |
| 2017-11-14 | Sale : show line 4 in the form | −20,000 | $40.05 | $801,000 | 1,530,216 | D |
| Open-market sales · 40,000 sh · avg $40.37 · $1,614,800 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-13 | Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) | −20,000 | 67,983 | D |
| 2017-11-14 | Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) | −20,000 | 47,983 | D |
Loading xslF345X03/doc4a.xml…